A clinical trial to compare different modalities of Radiotherapy in reducing the acute treatment toxicities of patients with cancer cervix.

Phase 3

Completed

• Conditions: Health Condition 1: null- Patients of Carcinoma Cervix

• Registration Number: CTRI/2016/12/007545
• Lead Sponsor: Postgraduate Institute of Medical Education and Research

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 36

Inclusion Criteria

Karnofsky performance scale > 70

Age < 70 years

Haemoglobin > 10gm/dl

TLC > 4000/cu mm

Platelets > 1 lakh/cu mm

Serum urea < 40 mg/dl

Serum creatinine < 1.2mg/dl

Exclusion Criteria

KPS < 60

All postoperative cases

Evidence of any metastatic disease at any time before or during treatment

Medical contraindications for concurrent chemotherapy

Patient refusal to participate in the study

Patients who have received chemoradiotherapy earlier

Patients having any uncontrolled co morbid conditions

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Evaluation of Acute ToxicitiesTimepoint: At the end of Brachytherapy

Secondary Outcome Measures

Name	Time	Method
ocal ControlTimepoint: At the end of one year